angiotensin ii has been researched along with carvedilol in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.50) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graham, BR; Prichard, BN; Tomlinson, B; Walden, RJ | 1 |
| Beermann, C; Belz, GG; Schloos, J | 1 |
| Gellai, M; Nichols, AJ; Ruffolo, RR | 1 |
| Colindres, RE; Cubeddu, LX; Fuenmayor, N; Powell, JR; Varin, F; Villagra, VG | 2 |
| Bompart, F; Graham, BR; Liu, JB; Prichard, BN; Tomlinson, B | 1 |
| Böhm, M; Buikema, H; Flesch, M; Paul, M; Pinto, YM; Teisman, AC; van Gilst, WH | 1 |
| Domoto, K; Ishikawa, Y; Kawasaki, S; Okuda, M; Taguchi, M; Takahashi, A; Takahashi, T; Taniguchi, T; Yokoyama, M | 1 |
| Burchardt, H; Davidsen, U; Heitmann, M; Petersen, EB; Rasmussen, K; Stokholm, KH | 1 |
| Anguita Sánchez, M | 1 |
| Jorde, UP; Katz, SD; Lang, CC; Mancini, DM; Packer, M; Vittorio, TJ | 1 |
| Ha, H; Kim, H; Kim, MS; Kim, YS; Lee, JH; Park, J; Park, K; Seo, J | 1 |
| Angielski, S; Dobrucki, LW; Jankowski, M; Kalinowski, L; Malinski, T; Martyniec, L; Szczepanska-Konkel, M | 1 |
| Barouhiel, E; Cabassi, A; Cantoni, AM; Cavazzini, S; Coghi, P; Fiaccadori, E; Govoni, P; Scandroglio, R; Speroni, E | 1 |
| Backes, RJ; Bailey, KR; Burnett, JC; Frantz, RP; Grill, D; Hanna, RD; Heublein, D; Mookadam, F; Moualla, SK; Nelson, SM; Nobrega, TP; Olson, LJ | 1 |
| Gao, LJ; Lin, XY; Xiao, LZ; Zhang, HF | 1 |
| Batenburg, WW; Danser, AH; Dekkers, DH; Garrelds, IM; Jorde, U; Kellett, E; Lamers, JM; Milligan, G; van Esch, JH; van Kats, JP; Walther, T | 1 |
| Devereux, RB; Krauser, DG | 1 |
| Abdulla, MH; Abdullah, NA; Johns, EJ; Khan, MA; Sattar, MA | 1 |
| Matsubara, BB; Matsubara, LS; Padovani, CR; Rocha, NS; Schwartz, DS; Vailati, Mdo C | 1 |
| Abdulla, MH; Abdullah, NA; Johns, EJ; Sattar, MA | 1 |
| Abd Elhameed, AG; Abu-Elsaad, NM; El-Karef, A; Ibrahim, TM | 1 |
| Geng, J; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Zhang, B; Zhang, Q | 1 |
| Li, Z; Wang, S; Wu, Y; Xiu, A; Zhang, C | 1 |
2 review(s) available for angiotensin ii and carvedilol
| Article | Year |
|---|---|
[Prevention and treatment of congestive heart failure in diabetic patients].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Meta-Analysis as Topic; Metoprolol; Prognosis; Propanolamines; Risk Factors; Time Factors | 2002 |
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan | 2006 |
9 trial(s) available for angiotensin ii and carvedilol
| Article | Year |
|---|---|
Clinical pharmacology of carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Hemodynamics; Humans; Labetalol; Male; Norepinephrine; Phenylephrine; Propanolamines; Vasodilator Agents | 1992 |
Constriction of human dorsal hand veins in vivo with several vasoconstrictors and the influence of oral administration of carvedilol.
Topics: Administration, Oral; Angiotensin II; Carbazoles; Carvedilol; Clonidine; Dinoprost; Dose-Response Relationship, Drug; Female; Hand; Humans; Male; Norepinephrine; Propanolamines; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Veins | 1992 |
Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Half-Life; Heart Rate; Humans; Isoproterenol; Labetalol; Phenylephrine; Propanolamines; Random Allocation; Vasodilation | 1987 |
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cold Temperature; Double-Blind Method; Exercise; Heart Rate; Hemodynamics; Humans; Hydralazine; Isoproterenol; Labetalol; Male; Middle Aged; Phenylephrine; Posture; Propanolamines; Propranolol; Vasodilator Agents | 1988 |
Clinical pharmacology of carvedilol in normal volunteers.
Topics: Adult; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Kinetics; Labetalol; Male; Phenylephrine; Propanolamines; Random Allocation; Receptors, Adrenergic | 1987 |
Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Diuretics; Drug Therapy, Combination; Glomerular Filtration Rate; Heart; Heart Failure; Heart Rate; Humans; Kidney; Middle Aged; Propanolamines; Renal Circulation | 2002 |
Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Metoprolol; Middle Aged; Propanolamines | 2003 |
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Endothelin-1; Endothelins; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines | 2005 |
[Effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin II; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Magnesium; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines | 2005 |
13 other study(ies) available for angiotensin ii and carvedilol
| Article | Year |
|---|---|
Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Arteries; Azepines; Calcium Channel Blockers; Carbazoles; Carvedilol; Consciousness; Dose-Response Relationship, Drug; Hemodynamics; Isoproterenol; Male; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Vasoconstrictor Agents; Vasodilation | 1991 |
Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Carbazoles; Carvedilol; Heart Function Tests; Hydralazine; Hypertension; Isoquinolines; Losartan; Norepinephrine; Propanolamines; Quinapril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrahydroisoquinolines | 1998 |
Participation of reactive oxygen intermediates in the angiotensin II-activated signaling pathways in vascular smooth muscle cells.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Carbazoles; Carvedilol; Cells, Cultured; Epidermal Growth Factor; Hydrogen Peroxide; Muscle, Smooth, Vascular; Propanolamines; Rats; Reactive Oxygen Species; Signal Transduction; Tetradecanoylphorbol Acetate | 2000 |
Effect of carvedilol alone or in the presence of cyclosporine on the migration of vascular smooth muscle cell of rat.
Topics: Angiotensin II; Animals; Carbazoles; Carvedilol; Cells, Cultured; Chemotaxis; Cyclosporine; Immunosuppressive Agents; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Propanolamines; Rats; Rats, Sprague-Dawley | 2003 |
Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Benzopyrans; Carbazoles; Carvedilol; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethanolamines; Extracellular Space; Gadolinium; Intracellular Fluid; Kidney Glomerulus; Luminescent Measurements; Male; Microcirculation; Nebivolol; Nitric Oxide; Propanolamines; Rats; Receptors, Purinergic P2; Suramin; Vasoconstriction; Vasodilation | 2003 |
Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Animals; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Glycerol; Heart Rate; Lipolysis; Losartan; Male; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Sterol Esterase; Sympathetic Nervous System; Triglycerides; Tyrosine 3-Monooxygenase | 2005 |
Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade.
Topics: Adolescent; Adrenergic Antagonists; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Carbazoles; Carvedilol; Coronary Vessels; Female; Humans; Inositol Phosphates; Irbesartan; Luciferases; Male; Metoprolol; Middle Aged; Myography; Propanolamines; Signal Transduction; Tetrazoles | 2006 |
Influence of sympathetic and AT-receptor blockade on angiotensin II and adrenergic agonist-induced renal vasoconstrictions in spontaneously hypertensive rats.
Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carbazoles; Carvedilol; Drug Interactions; Hypertension; Kidney; Losartan; Male; Propanolamines; Rats; Rats, Inbred SHR; Renal Circulation; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents | 2009 |
Protective effects of carvedilol on systemic vascular damage induced by angiotensin II: organ-specific effects independent of antihypertensive effects.
Topics: Analysis of Variance; Angiotensin II; Animals; Carbazoles; Carvedilol; Heart; Histocytochemistry; Kidney; Liver; Male; Necrosis; Propanolamines; Rats; Rats, Wistar; Systemic Vasculitis | 2010 |
The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.
Topics: Angiotensin II; Animals; Body Weight; Carbazoles; Carvedilol; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin Resistance; Kidney; Losartan; Male; Norepinephrine; Phenylephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2012 |
Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats.
Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Carvedilol; Cholesterol; Cytokines; Daucus carota; Doxorubicin; Functional Food; Heart; Lactobacillus acidophilus; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Oxidative Stress; Probiotics; Propanolamines; Rats, Sprague-Dawley; Yogurt | 2015 |
Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.
Topics: Alanine Transaminase; Angiotensin II; Animals; Aorta; Blood Pressure; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Constriction; Cystatin C; Denervation; Fibrosis; Heart Rate; Kidney; Malondialdehyde; Natriuretic Peptide, Brain; Organ Specificity; Oxidative Stress; Peptide Fragments; Procollagen; Propanolamines; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta1; Vascular Remodeling | 2016 |
Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway.
Topics: Angiotensin II; Animals; Carbon Tetrachloride Poisoning; Carvedilol; Cell Proliferation; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Mice; Receptor, Angiotensin, Type 1; rho-Associated Kinases; rhoA GTP-Binding Protein | 2019 |